TAME-PD - Physical Therapy, Atomoxetine and, Methylphenidate, to Enhance Gait and Balance in Parkinson's Disease: A Single Center, Randomized Pilot Study
Phase of Trial: Phase 0
Latest Information Update: 02 May 2017
At a glance
- Drugs Atomoxetine (Primary) ; Methylphenidate (Primary)
- Indications Gait disturbances; Parkinson's disease
- Focus Therapeutic Use
- Acronyms TAME-PD
- 09 Jan 2017 Planned End Date changed from 1 Sep 2018 to 1 Dec 2018.
- 09 Jan 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Dec 2017.
- 09 Jan 2017 Status changed from not yet recruiting to recruiting.